Anticholinesterases and anticholinergic drugs

Continuing Education in Anaesthesia, Critical Care and Pain

Volumn 4, Issue 5, 2004, Pages 164-168

  Priya Nair, V ^a   Hunter, Jennifer M ^a  

^a School of Anaesthesia   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33645598144     PISSN: 17431816     EISSN: 17431824     Source Type: Journal    
DOI: 10.1093/bjaceaccp/mkh045     Document Type: Article

References (6)

1. Martyn JJA, Standaert FG. Neuromuscular physiology and pharmacology. In: Miller RD, ed. Anesthesia, 5th Edn. Churchill Livingstone: New York, 2000; 735-51
2. Hunter JM. Muscle function and neuromuscular blockade. In: Aitkenhead AR, Rowbotham DJ, Smith G, eds. Textbook of Anaesthesia, 4th Edn. Churchill Livingstone: London, 2001; 223-35
3. White SM. Chemical and biological weapons: implications for anaesthesia and intensive care. Br J Anaesth 2002; 89: 306-24.
4. King JM, Hunter JM. Physiology of the neuromuscular junction. Br J AnaesthCEPD Reviews 2002; 2: 129-33.
5. Vickers MD, Morgan M, Spencer PSJ, Read MS. Parasympathomimetic and cholinergic agents; anticholinesterases. Drugs in Anaesthesia and Intensive Care Practice, 8th Edn. Butterworth Heinemann: Oxford, 1999; 296-7
6. Adam JM, Bennet JD, Bom A, et al. Cyclodextrin derived host molecules as reversal agents for the neuromuscular blocker rocuronium bromide: synthesis and structure-activity relationships. J Med Chem 2002; 45: 1806-16.